Literature DB >> 3366552

Crystal and molecular structure of Destruxin B.

J R Steiner1, C L Barnes.   

Abstract

The cyclic hexadepsipeptide mycotoxin Destruxin B, produced by Metarrhizium anisopliae, crystallizes in the orthorhombic space group P212121, with a = 11.010(2)A, b = 14.679(5)A, c = 21.273(7)A and Z = 4. The structure was solved by direct methods and refined by least-squares technique to a final unweighted R value of 0.051, for 3361 reflections with I greater than 3 sigma (I). The backbone of the peptide is asymmetric and is made of 5 trans peptide and ester units and 1 cis peptide unit. The backbone conformation of this cyclic depsipeptide is very similar to that of Roseotoxin B, an analogous mycotoxin produced by Trichothecium roseum. The conformation in the crystalline state also correlates well with the solution conformation, as reported from proton n.m.r. studies. The crystal packing is directed by van der Waals contacts.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3366552     DOI: 10.1111/j.1399-3011.1988.tb00025.x

Source DB:  PubMed          Journal:  Int J Pept Protein Res        ISSN: 0367-8377


  2 in total

1.  Rational design and synthesis of an orally bioavailable peptide guided by NMR amide temperature coefficients.

Authors:  Conan K Wang; Susan E Northfield; Barbara Colless; Stephanie Chaousis; Ingrid Hamernig; Rink-Jan Lohman; Daniel S Nielsen; Christina I Schroeder; Spiros Liras; David A Price; David P Fairlie; David J Craik
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-09       Impact factor: 11.205

2.  On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds.

Authors:  Tina R White; Chad M Renzelman; Arthur C Rand; Taha Rezai; Cayla M McEwen; Vladimir M Gelev; Rushia A Turner; Roger G Linington; Siegfried S F Leung; Amit S Kalgutkar; Jonathan N Bauman; Yizhong Zhang; Spiros Liras; David A Price; Alan M Mathiowetz; Matthew P Jacobson; R Scott Lokey
Journal:  Nat Chem Biol       Date:  2011-09-25       Impact factor: 15.040

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.